210 related articles for article (PubMed ID: 20562849)
21. Stromal and epithelial expression of tumor markers hyaluronic acid and HYAL1 hyaluronidase in prostate cancer.
Lokeshwar VB; Rubinowicz D; Schroeder GL; Forgacs E; Minna JD; Block NL; Nadji M; Lokeshwar BL
J Biol Chem; 2001 Apr; 276(15):11922-32. PubMed ID: 11278412
[TBL] [Abstract][Full Text] [Related]
22. Analysis of prostate cancer by proteomics using tissue specimens.
Liu AY; Zhang H; Sorensen CM; Diamond DL
J Urol; 2005 Jan; 173(1):73-8. PubMed ID: 15592032
[TBL] [Abstract][Full Text] [Related]
23. Thy1 (CD90) controls adipogenesis by regulating activity of the Src family kinase, Fyn.
Woeller CF; O'Loughlin CW; Pollock SJ; Thatcher TH; Feldon SE; Phipps RP
FASEB J; 2015 Mar; 29(3):920-31. PubMed ID: 25416548
[TBL] [Abstract][Full Text] [Related]
24. High expression of PSM-E correlated with tumor grade in prostate cancer: a new alternatively spliced variant of prostate-specific membrane antigen.
Cao KY; Mao XP; Wang DH; Xu L; Yuan GQ; Dai SQ; Zheng BJ; Qiu SP
Prostate; 2007 Dec; 67(16):1791-800. PubMed ID: 17929272
[TBL] [Abstract][Full Text] [Related]
25. Stromal activation associated with development of prostate cancer in prostate-targeted fibroblast growth factor 8b transgenic mice.
Elo TD; Valve EM; Seppänen JA; Vuorikoski HJ; Mäkelä SI; Poutanen M; Kujala PM; Härkönen PL
Neoplasia; 2010 Nov; 12(11):915-27. PubMed ID: 21076617
[TBL] [Abstract][Full Text] [Related]
26. Localization of CD44 and CD90 positive cells to the invasive front of breast tumors.
Donnenberg VS; Donnenberg AD; Zimmerlin L; Landreneau RJ; Bhargava R; Wetzel RA; Basse P; Brufsky AM
Cytometry B Clin Cytom; 2010 Sep; 78(5):287-301. PubMed ID: 20533389
[TBL] [Abstract][Full Text] [Related]
27. Novel biomarkers for prostate cancer including noncoding transcripts.
Romanuik TL; Ueda T; Le N; Haile S; Yong TM; Thomson T; Vessella RL; Sadar MD
Am J Pathol; 2009 Dec; 175(6):2264-76. PubMed ID: 19893039
[TBL] [Abstract][Full Text] [Related]
28. Differential Inductive Signaling of CD90 Prostate Cancer-Associated Fibroblasts Compared to Normal Tissue Stromal Mesenchyme Cells.
Pascal LE; Ai J; Vêncio RZ; Vêncio EF; Zhou Y; Page LS; True LD; Wang Z; Liu AY
Cancer Microenviron; 2011 Jan; 4(1):51-9. PubMed ID: 21505567
[TBL] [Abstract][Full Text] [Related]
29. Immunohistochemical analysis of the IL-6 family of cytokines and their receptors in benign, hyperplasic, and malignant human prostate.
Royuela M; Ricote M; Parsons MS; García-Tuñón I; Paniagua R; de Miguel MP
J Pathol; 2004 Jan; 202(1):41-9. PubMed ID: 14694520
[TBL] [Abstract][Full Text] [Related]
30. Stromal response to prostate cancer: nanotechnology-based detection of thioredoxin-interacting protein partners distinguishes prostate cancer associated stroma from that of benign prostatic hyperplasia.
Singer E; Linehan J; Babilonia G; Imam SA; Smith D; Loera S; Wilson T; Smith S
PLoS One; 2013; 8(6):e60562. PubMed ID: 23762225
[TBL] [Abstract][Full Text] [Related]
31. CD90 (Thy-1)-positive selection enhances osteogenic capacity of human adipose-derived stromal cells.
Chung MT; Liu C; Hyun JS; Lo DD; Montoro DT; Hasegawa M; Li S; Sorkin M; Rennert R; Keeney M; Yang F; Quarto N; Longaker MT; Wan DC
Tissue Eng Part A; 2013 Apr; 19(7-8):989-97. PubMed ID: 23216074
[TBL] [Abstract][Full Text] [Related]
32. High CD90 (THY-1) expression positively correlates with cell transformation and worse prognosis in basal-like breast cancer tumors.
Lobba ARM; Carreira ACO; Cerqueira OLD; Fujita A; DeOcesano-Pereira C; Osorio CAB; Soares FA; Rameshwar P; Sogayar MC
PLoS One; 2018; 13(6):e0199254. PubMed ID: 29949609
[TBL] [Abstract][Full Text] [Related]
33. Prostate cancer-associated gene expression alterations determined from needle biopsies.
Qian DZ; Huang CY; O'Brien CA; Coleman IM; Garzotto M; True LD; Higano CS; Vessella R; Lange PH; Nelson PS; Beer TM
Clin Cancer Res; 2009 May; 15(9):3135-42. PubMed ID: 19366833
[TBL] [Abstract][Full Text] [Related]
34. Mesenchymal Stem Cell Marker Expression in Gastric Cancer Stroma.
Numakura S; Uozaki H; Kikuchi Y; Watabe S; Togashi A; Watanabe M
Anticancer Res; 2019 Jan; 39(1):387-393. PubMed ID: 30591485
[TBL] [Abstract][Full Text] [Related]
35. Identification of stromally expressed molecules in the prostate by tag-profiling of cancer-associated fibroblasts, normal fibroblasts and fetal prostate.
Orr B; Riddick AC; Stewart GD; Anderson RA; Franco OE; Hayward SW; Thomson AA
Oncogene; 2012 Mar; 31(9):1130-42. PubMed ID: 21804603
[TBL] [Abstract][Full Text] [Related]
36. Differential expression of neuropilin-1 in malignant and benign prostatic stromal tissue.
Vanveldhuizen PJ; Zulfiqar M; Banerjee S; Cherian R; Saxena NK; Rabe A; Thrasher JB; Banerjee SK
Oncol Rep; 2003; 10(5):1067-71. PubMed ID: 12883660
[TBL] [Abstract][Full Text] [Related]
37. Human prostate cancer cells express neuroendocrine cell markers PGP 9.5 and chromogranin A.
Leiblich A; Cross SS; Catto JW; Pesce G; Hamdy FC; Rehman I
Prostate; 2007 Dec; 67(16):1761-9. PubMed ID: 17929277
[TBL] [Abstract][Full Text] [Related]
38. Cloning and characterization of UROC28, a novel gene overexpressed in prostate, breast, and bladder cancers.
An G; Ng AY; Meka CS; Luo G; Bright SP; Cazares L; Wright GL; Veltri RW
Cancer Res; 2000 Dec; 60(24):7014-20. PubMed ID: 11156405
[TBL] [Abstract][Full Text] [Related]
39. WDR19 expression is increased in prostate cancer compared with normal cells, but low-intensity expression in cancers is associated with shorter time to biochemical failures and local recurrence.
Lin B; Utleg AG; Gravdal K; White JT; Halvorsen OJ; Lu W; True LD; Vessella R; Lange PH; Nelson PS; Hood L; Kalland KH; Akslen LA
Clin Cancer Res; 2008 Mar; 14(5):1397-406. PubMed ID: 18316561
[TBL] [Abstract][Full Text] [Related]
40. Distinct biological characterization of the CD44 and CD90 phenotypes of cancer stem cells in gastric cancer cell lines.
Shu X; Liu H; Pan Y; Sun L; Yu L; Sun L; Yang Z; Ran Y
Mol Cell Biochem; 2019 Sep; 459(1-2):35-47. PubMed ID: 31073886
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
